---
title: "OCGN: Pivotal gene therapy trials for RP and Stargardt aim for global launches by 2028"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295568730.md"
description: "Late-stage gene therapy programs for blindness diseases are advancing, with pivotal data for RP and Stargardt expected in 2024 and potential global launches by 2028. The platform targets broad disease pathways, has strong safety data, and is supported by RMAT designation and extended financial runway.Based on DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source."
datetime: "2026-08-11T18:43:10.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295568730.md)
  - [en](https://longbridge.com/en/news/295568730.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295568730.md)
generator: "portal-rs"
---

# OCGN: Pivotal gene therapy trials for RP and Stargardt aim for global launches by 2028

Late-stage gene therapy programs for blindness diseases are advancing, with pivotal data for RP and Stargardt expected in 2024 and potential global launches by 2028. The platform targets broad disease pathways, has strong safety data, and is supported by RMAT designation and extended financial runway.

Based on 

**Disclaimer**

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

### Related Stocks

- [OCGN.US](https://longbridge.com/en/quote/OCGN.US.md)

## Related News & Research

- [Ocugen to Participate in Upcoming September Investor and Industry Conferences | OCGN Stock News](https://longbridge.com/en/news/296903578.md)
- [Ocugen to present modifier gene therapy platform at September investor conferences](https://longbridge.com/en/news/296902276.md)
- [10:31 ETLiver Cirrhosis Market to Expand Significantly Through 2036, Driven by Emerging Therapies and Increasing Disease Burden | DelveInsight](https://longbridge.com/en/news/296802956.md)
- [13:27 ETPatients Representing the Power of Advanced Therapies to Take Center Stage at Emily Whitehead Foundation's 2026 Believe Ball](https://longbridge.com/en/news/297074492.md)
- [America’s favorite cereals are getting a colorful makeover — without artificial dyes](https://longbridge.com/en/news/297201336.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**